{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:30:34Z","timestamp":1790364634288,"version":"4.1.0"},"reference-count":44,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Background: Sarcopenia is a muscle disease that occur across a lifetime. It is commonly described in the aging population but can occur earlier in life in patients with cancer. Previous studies demonstrated sarcopenia is highly prevalent in patients with gastroenteropancreatic neuroendocrine tumours (GEP-NETs). In solid organ cancers, such as colorectal or pancreatic cancer, the presence of sarcopenia is associated with surgical complications. It is unknown if sarcopenia in patients with GEP-NETs is a risk factor for surgical complications. Methods: A multicentre retrospective study was performed in patients with a recently diagnosed GEP-NET and surgery to the primary tumour. CT scans were analysed for body composition analyses to assess for the presence of sarcopenia. Data regarding surgical procedures and complications were collected. Any major surgical complication was considered as Clavien\u2013Dindo score \u2265 3. Results: This study included 180 patients, with 83 being male (46%) with a median age of 62 years (IQR 54\u201369). Most patients (n = 138, 77%) had a small intestinal NET, while 36 patients (20%) had pancreatic NETs. Sarcopenia was present in 109 patients (61%). In 43 patients (24%), surgical complications were recorded, and 21 complications (49%) were considered as major. Any type of surgical complication was not statistically different between patients without sarcopenia (n = 17, 24%) and with sarcopenia (n = 26, 24%)\u2014a p-value of 0.36. This was the same for major complications; between patients without sarcopenia (n = 5, 24%) and with sarcopenia (n = 16, 76%)\u2014a p-value of 0.18. Conclusions: Sarcopenia is highly prevalent in patients with a recently diagnosed GEP-NET, but this is not associated with major surgical complications. Future studies should include pathophysiological mechanisms that could be used to identify the causes of sarcopenia, its effect on quality of life and other oncological outcomes.<\/jats:p>","DOI":"10.3390\/nu16223790","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T06:30:48Z","timestamp":1730788248000},"page":"3790","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["High Prevalence of Sarcopenia in Patients with Newly Diagnosed Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETs), but No Association with the Risk of Surgical Complications"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8116-962X","authenticated-orcid":false,"given":"Dominique S. V. M.","family":"Clement","sequence":"first","affiliation":[{"name":"Kings Health Partners, ENETS Centre of Excellence, Institute of Liver Studies, King\u2019s College Hospital, London SE5 9RS, UK"},{"name":"Department of Gastroenterology, King\u2019s College Hospital, London SE5 9RS, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique E.","family":"van Leerdam","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Oncology, Netherlands Cancer Institute, ENETS Centre of Excellence, 1066 CX Amsterdam, The Netherlands"},{"name":"Department of Gastroenterology and Hepatology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margot E. T.","family":"Tesselaar","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Oncology, Netherlands Cancer Institute, ENETS Centre of Excellence, 1066 CX Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parthi","family":"Srinivasan","sequence":"additional","affiliation":[{"name":"Kings Health Partners, ENETS Centre of Excellence, Institute of Liver Studies, King\u2019s College Hospital, London SE5 9RS, UK"},{"name":"Department of Hepatopancreaticobiliairy Surgery, King\u2019s College Hospital, London SE5 9RS, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna","family":"Menon","sequence":"additional","affiliation":[{"name":"Kings Health Partners, ENETS Centre of Excellence, Institute of Liver Studies, King\u2019s College Hospital, London SE5 9RS, UK"},{"name":"Department of Hepatopancreaticobiliairy Surgery, King\u2019s College Hospital, London SE5 9RS, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koert","family":"Kuhlmann","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Netherlands Cancer Institute, ENETS Centre of Excellence, 1066 CX Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"den Hartog","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Netherlands Cancer Institute, ENETS Centre of Excellence, 1066 CX Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Giovos","sequence":"additional","affiliation":[{"name":"The ARDEN NET Centre, ENETS Centre of Excellence, University Hospitals Coventry and Warwickshire NHS Trust, Coventry CV2 2DX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4070-8164","authenticated-orcid":false,"given":"Martin O.","family":"Weickert","sequence":"additional","affiliation":[{"name":"The ARDEN NET Centre, ENETS Centre of Excellence, University Hospitals Coventry and Warwickshire NHS Trust, Coventry CV2 2DX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajaventhan","family":"Srirajaskanthan","sequence":"additional","affiliation":[{"name":"Kings Health Partners, ENETS Centre of Excellence, Institute of Liver Studies, King\u2019s College Hospital, London SE5 9RS, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO Classification of Tumours of the Digestive System","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/s41416-019-0606-3","article-title":"Impact of Neuroendocrine Morphology on Cancer Outcomes and Stage at Diagnosis: A UK Nationwide Cohort Study 2013\u20132015","volume":"121","author":"Genus","year":"2019","journal-title":"Br. J. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s11154-017-9438-8","article-title":"Hormone Secreting Gastro-Entero-Pancreatic Neuroendocrine Neoplasias (GEP-NEN): When to Consider, How to Diagnose?","volume":"18","author":"Fottner","year":"2017","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/postgradmedj-2017-134847","article-title":"Gastrointestinal Manifestations of Neuroendocrine Tumours: Their Investigation and Management","volume":"93","author":"Sagar","year":"2017","journal-title":"Postgrad. Med. J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1159\/000503634","article-title":"Nutritional Complications and the Management of Patients with Gastroenteropancreatic Neuroendocrine Tumors","volume":"110","author":"Laing","year":"2020","journal-title":"Neuroendocrinology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000488510","article-title":"Presenting Symptoms and Delay in Diagnosis of Gastrointestinal and Pancreatic Neuroendocrine Tumours","volume":"107","author":"Basuroy","year":"2018","journal-title":"Neuroendocrinology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/MPA.0000000000000818","article-title":"Patient-Reported Experience of Diagnosis, Management, and Burden of Neuroendocrine Tumors: Results from a Large Patient Survey in the United States","volume":"46","author":"Wolin","year":"2017","journal-title":"Pancreas"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.clnu.2015.03.001","article-title":"Diagnostic Criteria for Malnutrition\u2014An ESPEN Consensus Statement","volume":"34","author":"Cederholm","year":"2015","journal-title":"Clin. Nutr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: Revised European Consensus on Definition and Diagnosis","volume":"48","author":"Bahat","year":"2019","journal-title":"Age Ageing"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clnu.2018.08.002","article-title":"GLIM Criteria for the Diagnosis of Malnutrition\u2014A Consensus Report from the Global Clinical Nutrition Community","volume":"38","author":"Cederholm","year":"2019","journal-title":"Clin. Nutr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jne.13376","article-title":"The Global Leadership into Malnutrition Criteria Reveals a High Percentage of Malnutrition Which Influences Overall Survival in Patients with Gastroenteropancreatic Neuroendocrine Tumours","volume":"36","author":"Clement","year":"2024","journal-title":"J. Neuroendocrinol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e12695","DOI":"10.1111\/ecc.12695","article-title":"Prognostic Significance of Cachexia Score Assessed by CT in Male Patients with Small Cell Lung Cancer","volume":"27","author":"Kim","year":"2017","journal-title":"Eur. J. Cancer Care"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/MCO.0b013e328337d826","article-title":"Epidemiology of Myosteatosis","volume":"13","author":"Miljkovic","year":"2010","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00595-017-1564-0","article-title":"Sarcopenia Is an Independent Predictor of Complications after Colorectal Cancer Surgery","volume":"48","author":"Nakanishi","year":"2018","journal-title":"Surg. Today"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00384-017-2773-0","article-title":"Morphologic Change of the Psoas Muscle as a Surrogate Marker of Sarcopenia and Predictor of Complications after Colorectal Cancer Surgery","volume":"32","author":"Hanaoka","year":"2017","journal-title":"Int. J. Color. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.nut.2016.04.002","article-title":"A High Visceral Adipose Tissue-to-Skeletal Muscle Ratio as a Determinant of Major Complications after Pancreatoduodenectomy for Cancer","volume":"2","author":"Sandini","year":"2016","journal-title":"Nutrition"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s00384-016-2538-1","article-title":"Skeletal Muscle Mass and Quality as Risk Factors for Postoperative Outcome after Open Colon Resection for Cancer","volume":"31","author":"Boer","year":"2016","journal-title":"Int. J. Color. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"111156","DOI":"10.1016\/j.nut.2021.111156","article-title":"Measurement of Muscle Quantity\/Quality Has Additional Predictive Value for Postoperative Complications and Long-Term Survival after Gastrectomy for Gastric Cancer in Patients with Probable Sarcopenia as Defined by the New EWGSOP2 Consensus: Analysis From","volume":"86","author":"Huang","year":"2021","journal-title":"Nutrition"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/jso.23862","article-title":"Sarcopenia Is an Independent Predictor of Complications Following Pancreatectomy for Adenocarcinoma","volume":"111","author":"Joglekar","year":"2015","journal-title":"J. Surg. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Herrera-Mart\u00ednez, Y., Teomiro, C.A., Idougourram, S.L., Puertas, M.J.M., Continente, A.C., Blanch, R.S., Casta\u00f1o, J.P., Moreno, M.\u00c1.G., Gahete, M.D., and Luque, R.M. (2022). Sarcopenia and Ghrelin System in the Clinical Outcome and Prognosis of Gastroenteropancreatic Neuroendocrine Neoplasms. Cancers, 14.","DOI":"10.3390\/cancers14010111"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41430-021-00915-4","article-title":"Computed Tomography (CT)-Defined Sarcopenia and Myosteatosis Are Prevalent in Patients with Neuroendocrine Neoplasms (NENs) Treated with Peptide Receptor Radionuclide Therapy (PRRT)","volume":"76","author":"Chan","year":"2022","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Clement, D.S.V.M., va Leerdam, M.E., de Jong, S., Weickert, M.O., Ramage, J.K., Tesselaar, M.E.T., and Srirajaskanthan, R. (2023). Prevalence of Sarcopenia and Impact on Survival in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumours. Cancers, 15.","DOI":"10.3390\/cancers15030782"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index","volume":"31","author":"Martin","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_24","unstructured":"(2024, October 28). ASA Classification. Available online: https:\/\/www.asahq.org\/standards-and-guidelines\/asa-physical-status-classification-system."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of Surgical Complications: A New Proposal with Evaluation in a Cohort of 6336 Patients and Results of a Survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann. Surg."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1152\/japplphysiol.00744.2004","article-title":"Total Body Skeletal Muscle and Adipose Tissue Volumes: Estimation from a Single Abdominal Cross-Sectional Image","volume":"97","author":"Shen","year":"2004","journal-title":"J. Appl. Physiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1139\/H08-075","article-title":"A Practical and Precise Approach to Quantification of Body Composition in Cancer Patients Using Computed Tomography Images Acquired during Routine Care","volume":"33","author":"Mourtzakis","year":"2008","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.nutres.2012.12.007","article-title":"Establishing Computed Tomography-Defined Visceral Fat Area Thresholds for Use in Obesity-Related Cancer Research","volume":"33","author":"Doyle","year":"2013","journal-title":"Nutr. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"O256","DOI":"10.1111\/codi.13067","article-title":"Sarcopenia, as Defined by Low Muscle Mass, Strength and Physical Performance, Predicts Complications after Surgery for Colorectal Cancer","volume":"17","author":"Huang","year":"2015","journal-title":"Color. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1245\/s10434-016-5495-6","article-title":"Skeletal Muscle Quality Is Associated with Worse Survival After Pancreatoduodenectomy for Periampullary, Nonpancreatic Cancer","volume":"24","author":"Coelen","year":"2017","journal-title":"Ann. Surg. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"6973","DOI":"10.1158\/1078-0432.CCR-09-1525","article-title":"Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer","volume":"15","author":"Tan","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jpainsymman.2011.09.010","article-title":"Relationships among Body Mass Index, Longitudinal Body Composition Alterations, and Survival in Patients with Locally Advanced Pancreatic Cancer Receiving Chemoradiation: A Pilot Study","volume":"44","author":"Dalal","year":"2012","journal-title":"J. Pain Symptom Manag."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00595-017-1622-7","article-title":"Correlation between the Skeletal Muscle Index and Surgical Outcomes of Pancreaticoduodenectomy","volume":"48","author":"Sui","year":"2018","journal-title":"Surg. Today"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.ejso.2016.03.037","article-title":"Laparoscopic Colorectal Cancer Surgery Combined with Enhanced Recovery after Surgery Protocol (ERAS) Reduces the Negative Impact of Sarcopenia on Short-Term Outcomes","volume":"42","author":"Pisarska","year":"2016","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_35","unstructured":"NHS (2024, October 28). NHS Prevalence Obesity in the UK, Available online: https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/statistics-on-obesity-physical-activity-and-diet\/england-2020."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00268-015-3328-6","article-title":"Postoperative Complications, In-Hospital Mortality and 5-Year Survival after Surgical Resection for Patients with a Pancreatic Neuroendocrine Tumor: A Systematic Review","volume":"40","author":"Jilesen","year":"2016","journal-title":"World J. Surg."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e13008","DOI":"10.1111\/jne.13008","article-title":"Postoperative Morbidity and Mortality after Surgical Resection of Small Bowel Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis","volume":"33","author":"Chen","year":"2021","journal-title":"J. Neuroendocrinol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1677\/ERC-09-0042","article-title":"Midgut Neuroendocrine Tumours with Liver Metastases: Results of the UKINETS Study","volume":"16","author":"Ahmed","year":"2009","journal-title":"Endocr.-Relat. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/jamaoncol.2017.3326","article-title":"Association of a Prophylactic Surgical Approach to Stage IV Small Intestinal Neuroendocrine Tumors With Survival","volume":"4","author":"Daskalakis","year":"2018","journal-title":"JAMA Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000464292","article-title":"ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumours: Surgery for Small Intestinal and Pancreatic Neuroendocrine Tumours","volume":"105","author":"Partelli","year":"2017","journal-title":"Neuroendocrinology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"7822","DOI":"10.1245\/s10434-022-12030-0","article-title":"Primary Tumor Resection Is Associated with Improved Disease-Specific Mortality in Patients with Stage IV Small Intestinal Neuroendocrine Tumors (NETs): A Comparison of Upfront Surgical Resection Versus a Watch and Wait Strategy in Two Specialist NET Cente","volume":"12","author":"Levy","year":"2022","journal-title":"Ann. Surg. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000443170","article-title":"ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum","volume":"103","author":"Niederle","year":"2016","journal-title":"Neuroendocrinology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1634\/theoncologist.2017-0255","article-title":"Sarcopenia Is Associated with Quality of Life and Depression in Patients with Advanced Cancer","volume":"23","author":"Nipp","year":"2017","journal-title":"Oncologist"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.ejso.2021.03.004","article-title":"Sarcopenia Is a Predictive Factor of Poor Quality of Life and Prognosis in Patients after Radical Gastrectomy","volume":"47","author":"Zou","year":"2021","journal-title":"Eur. J. Surg. Oncol."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/16\/22\/3790\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:26:23Z","timestamp":1760113583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/16\/22\/3790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":44,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["nu16223790"],"URL":"https:\/\/doi.org\/10.3390\/nu16223790","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,5]]}}}